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and management1. Introduction
Signiﬁcant developmentin modern cardiac (or cardiovascular)
electrical devices (CIEDs), including permanent pacemakers,
implantable cardioverter-deﬁbrillators (ICDs), and cardiac resyn-
chronization therapy, is contributing to the improvement in both
the survival rate and quality of life in patients with cardiac
arrhythmias and/or heart failure. The number of CIED implanta-
tions has increased signiﬁcantly over the past decade based on
clinical evidence. However, CIED-related bacterial infections
remain one of the biggest and most serious complications of
their use.2. Incidence and risk factors
In a study involving Medicare administrative data, the
immediate post-procedural complications related to CIED
implantations decreased between 2002 and 2005 [1]. This favor-
able trend may be because of operators’ experience, technological
improvements, and device advances such as generator downsizing
and/or the use of more sophisticated equipment [2]. Hence,
focusing on device-related infections, the Nationwide Inpatient
Sample discharge records demonstrated that the annual rate of
CIED infections remained almost constant until 2004, but
increased suddenly after 2005, with a rate of 1.53% in 2004 to
2.41% in 2008 (po0.001) [3]. This study also revealed that the
incidence of four major comorbidities (renal failure, respiratory
failure, heart failure, and diabetes) in patients with CIED implan-
tations similarly remained almost constant until 2004, but
increased suddenly after 2005. This trend closely paralleled the
increase in the rate of CIED infections. Combined with an aging
population, rapid and widespread acceptance of ICD indication has
been suggested as a possible cause of the increase in the rate of
CIED infections. This is because the size of the ICD generator is
larger, and candidates for ICD therapy are more likely to have
additional comorbidities [3].
In the PEOPLE study, a multicenter prospective survey investi-
gating the incidence and risk factors of infectious complications in
CIED procedures, several characteristics (fever 24 h before
implantation, temporary pacing wires, and early intervention)
were identiﬁed as risk factors for infection. The study showed the
efﬁcacy of the prophylactic use of antibiotics (beta-lactam anti-
microbial agents) in the recipients of CIEDs [4]. Another case
control study showed that long-term corticosteroid use wasx.doi.org/10.1016/j.joa.2016.07.004
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reativecommons.org/licenses/by-nc-nd/4.0/).identiﬁed as an independent predictor of device infection [5]. The
Medicare administrative data study suggested a signiﬁcant role of
physician experience in CIED implantations [2]. In this study, a
signiﬁcantly higher rate of ICD infections was demonstrated in
patients whose device was implanted by operators in the lowest
quartile of implantation volume rather than by those in the
highest quartile of implantation volume.3. Management
For superﬁcial or incisional infections above the subcutaneous
pocket without device involvement, removal of the CIED is not
thought to be necessary [1]. However, even in cases with local
pocket infections without any signs of systemic infection, com-
plete removal of the entire system is recommended. Detailed
managements based on each patient's condition are discussed in
the following chapters in this special edition.co.4. Prognosis
Once a CIED-related infection occurs, each patient should be
carefully and intensively evaluated. Early diagnosis and appro-
priate therapy certainly provide a beneﬁcial effect on the patient's
outcome.
In one of the largest retrospective cohort studies involving data
of 200,219 patients from the Medicare system, CIED-related
infections were apparently associated with an increase in admis-
sions and the long-term mortality (adjusted long-term mortality
in patients with infections was 1.6- to 2.1-fold compared with
those without infections) [6]. Mortality in patients with infections
is reported to be in a wide range between 5% and 27% and is
suggested to be higher in patients with device-related endocarditis
and in those without device removal therapy [6–8]. The reportedopen access article under the CC BY-NC-ND license
Editorial / Journal of Arrhythmia 32 (2016) 245–246246parameters associated with mortality are systemic embolization,
moderate-to-severe tricuspid regurgitation, abnormal right ven-
tricular function, and abnormal renal function [8].5. Comments
CIED-related infections are increasing over time, and these
result in high hospital admission and mortality rates. However, the
development of several new technologies has contributed to
controlling this challenging problem.
In this special edition of the Journal of Arrhythmia featuring
CIED-related infections, we aim to cover various aspects of this
serious issue by inviting ﬁve experts in the ﬁeld of CIEDs to be the
main authors of each chapter. We deeply appreciate the efforts of
all authors for providing manuscripts and hope that their excellent
articles will maximize physicians’ performances in the manage-
ment of patients with CIEDs.References
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